Skip to main content

Niacin / simvastatin Pregnancy and Breastfeeding Warnings

Niacin / simvastatin is also known as: Simcor

Niacin / simvastatin Pregnancy Warnings

There are no data regarding the use of niacin in animal reproductive studies or controlled human pregnancy studies. While animal studies with simvastatin failed to reveal evidence of teratogenicity, animal studies with other HMG-CoA reductase inhibitors revealed an increase in the incidence of skeletal malformations. There are no controlled data on the use of simvastatin in human pregnancy. However, HMG-CoA reductase inhibitors are known to inhibit biosynthetic processes necessary in fetal development. Niacin-simvastatin may cause fetal harm when administered to a pregnant woman. Niacin-simvastatin is considered contraindicated for use during pregnancy.

See references

Niacin / simvastatin Breastfeeding Warnings

Nicotinic acid is excreted into human milk, but it is not known whether simvastatin is excreted into human milk. Small amounts of a similar HMG-CoA reductase inhibitor does pass into breast milk. Because of the potential for serious adverse reactions in nursing infants, women receiving niacin-simvastatin treatment should not breastfeed their infants.

See references

References for pregnancy information

  1. "Product Information. Simcor (niacin-simvastatin)." Abbott Pharmaceutical (2008):

References for breastfeeding information

  1. "Product Information. Simcor (niacin-simvastatin)." Abbott Pharmaceutical (2008):

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.